Transmission of human parvovirus B19 by coagulation factor concentrates. 1990

M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
Haematology Department, Children's Hospital, Birmingham, UK.

The prevalence of antibody to human parvovirus B19 was determined in 86 children with congenital bleeding disorders. Forty-seven of 53 boys (89%) receiving non-heat-treated factor VIII or prothrombin complex concentrates were anti-B19 IgG positive compared with 38% of their age-matched controls and 48% of children treated with cryoprecipitate. Acute B19 virus infection occurred in 2 boys 3-4 weeks after they had received the same batch of commercial factor VIII concentrate. Of 11 susceptible children who had only received heat-treated National Health Service factor VIII concentrate (8Y), 1 acquired anti-B19 IgG. This suggests that 8Y heat-treated concentrate has a much reduced risk of transmitting B19 virus and, by implication, other less heat-stable viruses such as human immunodeficiency virus.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010322 Parvoviridae Infections Virus infections caused by the PARVOVIRIDAE. Parvovirus Infections,Infections, Parvoviridae,Infections, Parvovirus,Infection, Parvoviridae,Infection, Parvovirus,Parvoviridae Infection,Parvovirus Infection
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
December 1994, Nouvelle revue francaise d'hematologie,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
November 2002, Transfusion,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
May 1997, Transfusion,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
October 2004, Thrombosis and haemostasis,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
July 1992, British journal of haematology,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
June 1994, Lancet (London, England),
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
June 2008, Transfusion,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
May 1996, British journal of haematology,
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
August 1983, Lancet (London, England),
M D Williams, and B J Cohen, and A C Beddall, and K J Pasi, and P P Mortimer, and F G Hill
June 2005, Transfusion,
Copied contents to your clipboard!